Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A

2(66.7%)

Phase 4

1(33.3%)

3Total

N/A(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06842082Not ApplicableCompleted

The Videolaryngoscopy Versus Direct Laringoscopy for Residents Intubation Study

Role: lead

NCT05983978Recruiting

No-biopsy Approach in Celiac Disease: Cut-off Points for IgA Anti-tissue Transglutaminase Assays

Role: collaborator

NCT06378294Active Not Recruiting

Locoregional Control With Radiotherapy of Breast Cancer Patients With MACrometastases Treated With MAstectomy (MACMA)

Role: collaborator

NCT05781243Phase 4Completed

Normal Saline Versus Lactated Ringer's Solution for Acute Pancreatitis Resuscitation

Role: collaborator

NCT06286007Recruiting

Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control

Role: collaborator

NCT04663893Recruiting

Peri-Implant and Peri-Prosthetic Fractures: Epidemiology, Morbidity, Mortality, Treatment and Outcome Analysis

Role: collaborator

NCT05186220Not ApplicableUnknown

Cardioneuroablation Versus Pacemaker Implantation for the Treatment of Symptomatic Sinus Node Dysfunction

Role: collaborator

NCT02501070Completed

Impact on Public HEalth of a Network in Acute Myocardial Infarction Care

Role: collaborator

All 8 trials loaded